Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of the Effectiveness and Safety of Nivolumab Compared to Bevacizumab and of Nivolumab With or Without Ipilimumab in Glioblastoma Patients (CheckMate 143)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02017717
Recruitment Status : Active, not recruiting
First Posted : December 23, 2013
Last Update Posted : April 19, 2021
Sponsor:
Information provided by (Responsible Party):
Bristol-Myers Squibb